Arteriovenous fistula in kidney transplant recipients: from essential to undesirable

Authors

  • Rafael Enrique Cruz Abascal Hospital Provincial Clínico-Quirúrgico Universitario “Arnaldo Milián Castro”, Unidad de Trasplante Renal, Servicio de Nefrología, Cuba. Médico especialista de segundo grado en nefrología, máster en Enfermedades Infecciosas; profesor titular e investigador auxiliar. https://orcid.org/0000-0002-6028-3255

DOI:

https://doi.org/10.24265/horizmed.2025.v25n1.00

Abstract

The surgically created arteriovenous fistula (AVF), first introduced by Cimino and Brescia (1) in collaboration with surgeon Appel in 1966 for chronic hemodialysis, remains the preferred long-term vascular access for patients with chronic kidney disease (CKD). It provides optimal dialysis adequacy, enhances quality of life, reduces complications, and improves survival rates.

Downloads

Download data is not yet available.

References

Brescia MJ, Cimino JE, Appel K, Hurwich BJ. Chronic hemodialysis venipuncture and a surgically created arteriovenous fistula. N Engl J Med [Internet].

;275(20):1089-92.

Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol [Internet]. 2008;52(19):1527-39.

Hung TW, Wu SW, Chiou JY, Wang YH, Liao YC, Wei CC. Association of permanent vascular access dysfunction with subsequent risk of cardiovascular

disease: A population–based cohort study. J Pers Med [Internet]. 2022;12(4):598.

Basile C, Lomonte C. The arteriovenous fistula is a blessing of God. Nephrol Dial Transplant [Internet]. 2012;27(10):3752-6.

Ikizler TA. Arteriovenous fistulas in patients with kidney transplantation. Kidney Int [Internet]. 2020;97(1):20-1.

Voorzaat BM, Janmaat CJ, Wilschut ED, Van Der Bogt KEA, Dekker FW, Rotmans JI. No consensus on physician’s preferences on vascular access

management after kidney transplantation: Results of a multi-national survey. J Vasc Access [Internet]. 2019;20(1):52-9.

Kotta PA, Elango M, Papalois V. Preoperative cardiovascular assessment of the renal transplant recipient: a narrative review. J Clin Med [Internet].

;10(11):1-27.

Rao NN, Stokes MB, Rajwani A, Ullah S, Williams K, King D, et al. Effects of arteriovenous fistula ligation on cardiac structure and function in kidney

transplant recipients. Circulation [Internet]. 2019;139(25):2809-18.

Zheng H, Bu S, Song Y, Wang M, Wu J, Chen J. To ligate or not to ligate: A meta-analysis of cardiac effects and allograft function following

arteriovenous fistula closure in renal transplant recipients. Ann Vasc Surg [Internet]. 2020;63:287-92.

Cruz RE. Fístula arteriovenosa para hemodiálisis en receptores de trasplante renal e implicaciones en el síndrome cardiorrenal tipo 4. Revista Cubana

de Medicina [Internet]. 2022;61(2):e2590.

Downloads

Published

2025-03-12

How to Cite

1.
Cruz Abascal RE. Arteriovenous fistula in kidney transplant recipients: from essential to undesirable. Horiz Med [Internet]. 2025Mar.12 [cited 2025May1];25(1):e3013. Available from: https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/3013

Issue

Vol. 25 No. 1 (2025): Enero-Marzo

Section

Editorial

License

Copyright (c) 1970 Horizonte Médico (Lima)

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Horizonte Médico (Lima) (Horiz. Med.) journal’s research outputs are published free of charge and are freely available to download under the open access model, aimed at disseminating works and experiences developed in biomedical and public health areas, both nationally and internationally, and promoting research in the different fields of human medicine. All manuscripts accepted and published in the journal are distributed free of charge under the terms of a Creative Commons license – Attribution 4.0 International (CC BY 4.0).